{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:44:15Z","timestamp":1791553455797,"version":"4.3.4"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T00:00:00Z","timestamp":1520208000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1038\/cmi.2017.151","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T04:40:59Z","timestamp":1520224859000},"page":"586-594","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":365,"title":["Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction"],"prefix":"10.1038","volume":"15","author":[{"given":"Yahel","family":"Segal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,5]]},"reference":[{"key":"135_CR1","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S0140-6736(62)91653-7","volume":"279","author":"M Kaplan","year":"1962","unstructured":"Kaplan M, Meyeserian M. An immunological cross-reaction between group\u2014a streptococcal cells and human heart tissue. Lancet 1962; 279: 706\u2013710.","journal-title":"Lancet"},{"key":"135_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/193151a0","volume":"193","author":"D Rowley","year":"1962","unstructured":"Rowley D, Jenkin CR. Antigenic cross-reaction between host and parasite as a possible cause of pathogenicity. Nature 1962; 193: 151\u2013154.","journal-title":"Nature"},{"key":"135_CR3","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1096\/fasebj.12.13.1255","volume":"12","author":"MB Oldstone","year":"1998","unstructured":"Oldstone MB. Molecular mimicry and immune-mediated diseases. FASEB J 1998; 12: 1255\u20131265.","journal-title":"FASEB J"},{"key":"135_CR4","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.peptides.2008.05.022","volume":"29","author":"D Kanduc","year":"2008","unstructured":"Kanduc D, Stufano A, Lucchese G, Kusalik A. Massive peptide sharing between viral and human proteomes. Peptides 2008; 29: 1755\u20131766.","journal-title":"Peptides"},{"key":"135_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4161\/self.1.3.11897","volume":"1","author":"D Kanduc","year":"2010","unstructured":"Kanduc D. The self\/nonself issue. Self Nonself 2010; 1: 255\u2013258.","journal-title":"Self Nonself"},{"key":"135_CR6","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0961203309346653","volume":"18","author":"N Agmon-Levin","year":"2009","unstructured":"Agmon-Levin N, Blank M, Paz Z, Shoenfeld Y. Molecular mimicry in systemic lupus erythematosus. Lupus 2009; 18: 1181\u20131185.","journal-title":"Lupus"},{"key":"135_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1126\/science.85.2206.356","volume":"85","author":"GDH Carpenter","year":"1937","unstructured":"Carpenter GDH. Mimicry, as viewed by Professor Shull. Science 1937; 85: 356\u2013359.","journal-title":"Science"},{"key":"135_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1086\/282313","volume":"98","author":"RT Damian","year":"1964","unstructured":"Damian RT. Molecular mimicry: antigen sharing by parasite and host and its consequences. Am Nat 1964; 98: 129\u2013149.","journal-title":"Am Nat"},{"key":"135_CR9","first-page":"65","volume":"8","author":"D Kanduc","year":"2009","unstructured":"Kanduc D. Quantifying the possible cross-reactivity risk of an HPV16 vaccine. ResearchGate 2009; 8: 65\u201376.","journal-title":"ResearchGate"},{"key":"135_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.4161\/self.1.4.13315","volume":"1","author":"B Trost","year":"2010","unstructured":"Trost B, Lucchese G, Stufano A, Bickis M, Kusalik A, Kanduc D. No human protein is exempt from bacterial motifs, not even one. Self Nonself 2010; 1: 328\u2013334.","journal-title":"Self Nonself"},{"key":"135_CR11","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.2741\/s341","volume":"4","author":"D Kanduc","year":"2012","unstructured":"Kanduc D. Peptide cross-reactivity: theoriginal sin of vaccines. Front Biosci School Ed 2012; 4: 1393\u20131401.","journal-title":"Front Biosci School Ed"},{"issue":"(Part 1)","key":"135_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/SQB.1989.054.01.003","volume":"54","author":"CA Janeway","year":"1989","unstructured":"Janeway CA. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989; 54 (Part 1): 1\u201313.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"135_CR13","doi-asserted-by":"crossref","unstructured":"Arango M-T, Perricone C, Kivity S, Cipriano E, Ceccarelli F, Valesini G et al. HLA-DRB1 the notorious gene in the mosaic of autoimmunity. Immunol Res 2016, 1\u201317.","DOI":"10.1007\/s12026-016-8817-7"},{"key":"135_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1172\/JCI12634","volume":"107","author":"G S\u00f8nderstrup","year":"2001","unstructured":"S\u00f8nderstrup G, McDevitt HO. DR, DQ, and you: MHC alleles and autoimmunity. J Clin Invest 2001; 107: 795\u2013796.","journal-title":"J Clin Invest"},{"key":"135_CR15","doi-asserted-by":"crossref","unstructured":"Fernando MMA, Stevens CR, Walsh EC, De Jager PL, Goyette P, Plenge RM et al. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet [Internet] 2008; 4: e1000024. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2291482\/.","DOI":"10.1371\/journal.pgen.1000024"},{"key":"135_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13059-017-1207-1","volume":"18","author":"V Matzaraki","year":"2017","unstructured":"Matzaraki V, Kumar V, Wijmenga C, Zhernakova A. The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biol 2017; 18: 76.","journal-title":"Genome Biol"},{"key":"135_CR17","unstructured":"Taneja V, Mangalem A, David CS. Genetic predisposition to autoimmune diseases conferred by the major histocompatibility complex: utility of animal models. In: Mackay IR, Rose NR (eds). The Autoimmune Diseases. Academic Press: New York, NY, 2013; pp 365\u2013377."},{"key":"135_CR18","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nrrheum.2017.42","volume":"13","author":"S Dahan","year":"2017","unstructured":"Dahan S, Segal Y, Shoenfeld Y. Dietary factors in rheumatic autoimmune diseases: a recipe for therapy? Nat Rev Rheumatol 2017; 13: 348\u2013358.","journal-title":"Nat Rev Rheumatol"},{"key":"135_CR19","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.autrev.2016.01.001","volume":"15","author":"C Perricone","year":"2016","unstructured":"Perricone C, Versini M, Ben-Ami D, Gertel S, Watad A, Segel MJ et al. Smoke and autoimmunity: The fire behind the disease. Autoimmun Rev 2016; 15: 354\u2013374.","journal-title":"Autoimmun Rev"},{"key":"135_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/ncprheum0989","volume":"5","author":"N Shoenfeld","year":"2009","unstructured":"Shoenfeld N, Amital H, Shoenfeld Y. The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease. Nat Clin Pract Rheumatol 2009; 5: 99\u2013105.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"135_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/BOR.0000000000000008","volume":"26","author":"SB Brusca","year":"2014","unstructured":"Brusca SB, Abramson SB, Scher JU. Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity. Curr Opin Rheumatol 2014; 26: 101\u2013107.","journal-title":"Curr Opin Rheumatol"},{"key":"135_CR22","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nature08157","volume":"459","author":"G Neumann","year":"2009","unstructured":"Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009; 459: 931\u2013939.","journal-title":"Nature"},{"key":"135_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2014.01.033","volume":"50","author":"SS Ahmed","year":"2014","unstructured":"Ahmed SS, Schur PH, MacDonald NE, Steinman L. Narcolepsy, 2009A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. J Autoimmun 2014; 50: 1\u201311.","journal-title":"J Autoimmun"},{"key":"135_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.phrs.2014.10.005","volume":"92","author":"M-T Arango","year":"2015","unstructured":"Arango M-T, Kivity S, Shoenfeld Y. Is narcolepsy a classical autoimmune disease? Pharmacol Res 2015; 92: 6\u201312.","journal-title":"Pharmacol Res"},{"key":"135_CR25","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S1474-4422(14)70075-4","volume":"13","author":"M Partinen","year":"2014","unstructured":"Partinen M, Kornum BR, Plazzi G, Jennum P, Julkunen I, Vaarala O. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol 2014; 13: 600\u2013613.","journal-title":"Lancet Neurol"},{"key":"135_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1749-6632.2010.05513.x","volume":"1200","author":"T Sakurai","year":"2010","unstructured":"Sakurai T, Mieda M, Tsujino N. The orexin system: roles in sleep\/wake regulation. Ann NY Acad Sci 2010; 1200: 149\u2013161.","journal-title":"Ann NY Acad Sci"},{"key":"135_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaut.2013.06.010","volume":"45","author":"A Katzav","year":"2013","unstructured":"Katzav A, Arango MT, Kivity S, Tanaka S, Givaty G, Agmon-Levin N et al. Passive transfer of narcolepsy: anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice. J Autoimmun 2013; 45: 24\u201330.","journal-title":"J Autoimmun"},{"key":"135_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jaut.2013.02.003","volume":"43","author":"AK Singh","year":"2013","unstructured":"Singh AK, Mahlios J, Mignot E. Genetic association, seasonal infections and autoimmune basis of narcolepsy. J Autoimmun 2013; 43: 26\u201331.","journal-title":"J Autoimmun"},{"key":"135_CR29","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/ana.22587","volume":"70","author":"F Han","year":"2011","unstructured":"Han F, Lin L, Warby SC, Faraco J, Li J, Dong SX et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 2011; 70: 410\u2013417.","journal-title":"Ann Neurol"},{"key":"135_CR30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000111581","volume":"29","author":"D Picchioni","year":"2007","unstructured":"Picchioni D, Hope CR, Harsh JR. A case\u2013control study of the environmental risk factors for narcolepsy. Neuroepidemiology 2007; 29: 185\u2013192.","journal-title":"Neuroepidemiology"},{"key":"135_CR31","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.5665\/sleep.5752","volume":"39","author":"J Stowe","year":"2016","unstructured":"Stowe J, Andrews N, Kosky C, Dennis G, Eriksson S, Hall A et al. Risk of narcolepsy after AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine in adults: a case-coverage study in England. Sleep 2016; 39: 1051\u20131057.","journal-title":"Sleep"},{"key":"135_CR32","unstructured":"Lakemedelsverket M. Occurrence of narcolepsy with cata-plexy among children and adolescents in relation to the H1N1 pandemic and Pandemrix vaccinations: results of a case inventory study by the MPA in Sweden during 2009\u20132010. 2011; 1: 1\u201320."},{"key":"135_CR33","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.sleep.2013.03.020","volume":"14","author":"MS Heier","year":"2013","unstructured":"Heier MS, Gautvik KM, Wannag E, Bronder KH, Midtlyng E, Kamaleri Y et al. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Med 2013; 14: 867\u2013871.","journal-title":"Sleep Med"},{"key":"135_CR34","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1093\/brain\/awt187","volume":"136","author":"Y Dauvilliers","year":"2013","unstructured":"Dauvilliers Y, Arnulf I, Lecendreux M, Monaca Charley C, Franco P, Drouot X et al. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain 2013; 136: 2486\u20132496.","journal-title":"Brain"},{"key":"135_CR35","unstructured":"Department of Health (DoH). Investigation of an increase in the incidence of narcolepsy in children and adolescents in 2009 and 2010 Final Report of National Narcolepsy Study Steering Committee [Internet]. 2012 Apr (cited 13 August 2017). Available at: http:\/\/www.lenus.ie\/hse\/handle\/10147\/219671."},{"key":"135_CR36","doi-asserted-by":"publisher","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","volume":"7","author":"H Nohynek","year":"2012","unstructured":"Nohynek H, Jokinen J, Partinen M, Vaarala O, Kirjavainen T, Sundman J et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS ONE 2012; 7: e33536.","journal-title":"PLoS ONE"},{"key":"135_CR37","doi-asserted-by":"publisher","first-page":"f794","DOI":"10.1136\/bmj.f794","volume":"346","author":"E Miller","year":"2013","unstructured":"Miller E, Andrews N, Stellitano L, Stowe J, Winstone AM, Shneerson J et al. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine: retrospective analysis. BMJ 2013; 346: f794.","journal-title":"BMJ"},{"key":"135_CR38","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.3201\/eid1611.100323","volume":"16","author":"X Wang","year":"2010","unstructured":"Wang X, Yang P, Seale H, Zhang Y, Deng Y, Pang X et al. Estimates of the true number of cases of pandemic (H1N1) 2009, Beijing, China. Emerg Infect Dis 2010; 16: 1786\u20131788.","journal-title":"Emerg Infect Dis"},{"key":"135_CR39","doi-asserted-by":"publisher","first-page":"294ra105","DOI":"10.1126\/scitranslmed.aab2354","volume":"7","author":"SS Ahmed","year":"2015","unstructured":"Ahmed SS, Volkmuth W, Duca J, Corti L, Pallaoro M, Pezzicoli A et al. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Sci Transl Med 2015; 7: 294ra105.","journal-title":"Sci Transl Med"},{"key":"135_CR40","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1080\/21645515.2016.1171439","volume":"12","author":"SS Ahmed","year":"2016","unstructured":"Ahmed SS, Steinman L. Mechanistic insights into influenza vaccine-associated narcolepsy. Hum Vaccines Immunother 2016; 12: 3196\u20133201.","journal-title":"Hum Vaccines Immunother"},{"key":"135_CR41","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1159\/000237258","volume":"109","author":"Y Shoenfeld","year":"1996","unstructured":"Shoenfeld Y, George J, Peter JB. Guillain-Barr\u00e9 as an autoimmune disease. Int Arch Allergy Immunol. 1996; 109: 318\u2013326.","journal-title":"Int Arch Allergy Immunol."},{"key":"135_CR42","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMra1114525","volume":"366","author":"N Yuki","year":"2012","unstructured":"Yuki N, Hartung H-P. Guillain-Barr\u00e9 syndrome. N Engl J Med 2012; 366: 2294\u20132304.","journal-title":"N Engl J Med"},{"key":"135_CR43","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1084\/jem.178.5.1771","volume":"178","author":"N Yuki","year":"1993","unstructured":"Yuki N, Taki T, Inagaki F, Kasama T, Takahashi M, Saito K et al. A bacterium lipopolysaccharide that elicits Guillain-Barr\u00e9 syndrome has a GM1 ganglioside-like structure. J Exp Med 1993; 178: 1771\u20131775.","journal-title":"J Exp Med"},{"key":"135_CR44","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1586\/1744666X.2013.811119","volume":"9","author":"BR Wakerley","year":"2013","unstructured":"Wakerley BR, Yuki N. Infectious and noninfectious triggers in Guillain-Barr\u00e9 syndrome. Expert Rev Clin Immunol 2013; 9: 627\u2013639.","journal-title":"Expert Rev Clin Immunol"},{"key":"135_CR45","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","volume":"110","author":"LB Schonberger","year":"1979","unstructured":"Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, Keenlyside RA, Ziegler DW, Retailliau HF et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977. Am J Epidemiol 1979; 110: 105\u2013123.","journal-title":"Am J Epidemiol"},{"key":"135_CR46","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1086\/589624","volume":"198","author":"I Nachamkin","year":"2008","unstructured":"Nachamkin I, Shadomy SV, Moran AP, Cox N, Fitzgerald C, Ung H et al. Anti-ganglioside antibody induction by swine (A\/NJ\/1976\/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barr\u00e9 syndrome. J Infect Dis 2008; 198: 226\u2013233.","journal-title":"J Infect Dis"},{"key":"135_CR47","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1586\/1744666X.2013.824686","volume":"9","author":"DA Salmon","year":"2013","unstructured":"Salmon DA, Vellozzi C, Chen RT, Halsey NA. Did the influenza A (H1N1) 2009 monovalent inactivated vaccines increase the risk for Guillain-Barr\u00e9 syndrome? Expert Rev Clin Immunol 2013; 9: 795\u2013797.","journal-title":"Expert Rev Clin Immunol"},{"key":"135_CR48","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","volume":"384","author":"C Tr\u00e9po","year":"2014","unstructured":"Tr\u00e9po C, Chan HLY, Lok A. Hepatitis B virus infection. Lancet Lond Engl 2014; 384: 2053\u20132063.","journal-title":"Lancet Lond Engl"},{"key":"135_CR49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12016-007-8013-6","volume":"34","author":"R Maya","year":"2008","unstructured":"Maya R, Gershwin ME, Shoenfeld Y. Hepatitis B virus (HBV) and autoimmune disease. Clin Rev Allergy Immunol 2008; 34: 85\u2013102.","journal-title":"Clin Rev Allergy Immunol"},{"key":"135_CR50","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/255104a0","volume":"255","author":"AJ Zuckerman","year":"1975","unstructured":"Zuckerman AJ. Hepatitis vaccine: a note of caution. Nature 1975; 255: 104\u2013105.","journal-title":"Nature"},{"key":"135_CR51","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/oxfordjournals.aje.a114808","volume":"127","author":"FE Shaw","year":"1988","unstructured":"Shaw FE, Graham DJ, Guess HA, Milstien JB, Johnson JM, Schatz GC et al. Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years. Am J Epidemiol 1988; 127: 337\u2013352.","journal-title":"Am J Epidemiol"},{"key":"135_CR52","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/0140-6736(91)92034-Y","volume":"338","author":"L Herroelen","year":"1991","unstructured":"Herroelen L, de Keyser J, Ebinger G. Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine. Lancet Lond Engl 1991; 338: 1174\u20131175.","journal-title":"Lancet Lond Engl"},{"key":"135_CR53","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1136\/jnnp.58.6.758-a","volume":"58","author":"G Kaplanski","year":"1995","unstructured":"Kaplanski G, Retornaz F, Durand J, Soubeyrand J. Central nervous system demyelination after vaccination against hepatitis B and HLA haplotype. J Neurol Neurosurg Psychiatry 1995; 58: 758\u2013759.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"135_CR54","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0198-8859(82)90036-2","volume":"4","author":"E Gy\u00f3di","year":"1982","unstructured":"Gy\u00f3di E, Benczur M, P\u00e1lffy G, T\u00e1las M, Petr\u00e1nyi G, F\u00f6ldes I et al. Association between HLA B7, DR2 and dysfunction of natural- and antibody-mediated cytotoxicity without connection with the deficient interferon production in multiple sclerosis. Hum Immunol 1982; 4: 209\u2013217.","journal-title":"Hum Immunol"},{"key":"135_CR55","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S1474-4422(03)00663-X","volume":"3","author":"DA Dyment","year":"2004","unstructured":"Dyment DA, Ebers GC, Sadovnick AD. Genetics of multiple sclerosis. Lancet Neurol 2004; 3: 104\u2013110.","journal-title":"Lancet Neurol"},{"key":"135_CR56","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0167-5699(89)90245-4","volume":"10","author":"Y Shoenfeld","year":"1989","unstructured":"Shoenfeld Y, Isenberg DA. The mosaic of autoimmunity. Immunol Today 1989; 10: 123\u2013126.","journal-title":"Immunol Today"},{"key":"135_CR57","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1741-7015-11-101","volume":"11","author":"C Perricone","year":"2013","unstructured":"Perricone C, Agmon-Levin N, Shoenfeld Y. Novel pebbles in the mosaic of autoimmunity. BMC Med 2013; 11: 101.","journal-title":"BMC Med"},{"key":"135_CR58","first-page":"3","volume":"10","author":"Y Shoenfeld","year":"2008","unstructured":"Shoenfeld Y, Gilburd B, Abu-Shakra M, Amital H, Barzilai O, Berkun Y et al. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases\u20142008. Isr Med Assoc J 2008; 10: 3\u20137.","journal-title":"Isr Med Assoc J"},{"key":"135_CR59","first-page":"151","volume":"22","author":"O Gout","year":"2001","unstructured":"Gout O. Vaccinations and multiple sclerosis. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 2001; 22: 151\u2013154.","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"key":"135_CR60","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.autrev.2004.10.002","volume":"4","author":"M Girard","year":"2005","unstructured":"Girard M. Autoimmune hazards of hepatitis B vaccine. Autoimmun Rev 2005; 4: 96\u2013100.","journal-title":"Autoimmun Rev"},{"key":"135_CR61","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0264-410X(97)00214-4","volume":"16","author":"I Grotto","year":"1998","unstructured":"Grotto I, Mandel Y, Ephros M, Ashkenazi I, Shemer J. Major adverse reactions to yeast-derived hepatitis B vaccines\u2014a review. Vaccine 1998; 16: 329\u2013334.","journal-title":"Vaccine"},{"key":"135_CR62","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1046\/j.1529-8027.2002.02010.x","volume":"7","author":"C Vital","year":"2002","unstructured":"Vital C, Vital A, Gbikpi-Benissan G, Longy-Boursier M, Climas M-T, Castaing Y et al. Postvaccinal inflammatory neuropathy: peripheral nerve biopsy in 3 cases. J Peripher Nerv Syst 2002; 7: 163\u2013167.","journal-title":"J Peripher Nerv Syst"},{"issue":"(Part 1)","key":"135_CR63","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1542\/peds.110.1.e4","volume":"110","author":"C Belloni","year":"2002","unstructured":"Belloni C, Avanzini MA, De Silvestri A, Martinetti M, Pasi A, Coslovich E et al. No evidence of autoimmunity in 6-year-old children immunized at birth with recombinant hepatitis B vaccine. Pediatrics 2002; 110 (Part 1): e4.","journal-title":"Pediatrics"},{"key":"135_CR64","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/S0264-410X(99)00533-2","volume":"18","author":"P Monteyne","year":"2000","unstructured":"Monteyne P, Andr\u00e9 FE. Is there a causal link between hepatitis B vaccination and multiple sclerosis? Vaccine 2000; 18: 1994\u20132001.","journal-title":"Vaccine"},{"key":"135_CR65","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1001\/jamaneurol.2014.2633","volume":"71","author":"A Langer-Gould","year":"2014","unstructured":"Langer-Gould A, Qian L, Tartof SY, Brara SM, Jacobsen SJ, Beaber BE et al. Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases. JAMA Neurol 2014; 71: 1506\u20131513.","journal-title":"JAMA Neurol"},{"key":"135_CR66","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1365-2893.2003.00423.x","volume":"10","author":"V Demicheli","year":"2003","unstructured":"Demicheli V, Rivetti A, Pietrantonj CD, Clements CJ, Jefferson T. Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review. J Viral Hepat 2003; 10: 343\u2013344.","journal-title":"J Viral Hepat"},{"key":"135_CR67","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1001\/archneur.60.4.504","volume":"60","author":"F DeStefano","year":"2003","unstructured":"DeStefano F, Verstraeten T, Jackson LA, Okoro CA, Benson P, Black SB et al. Vaccinations and risk of central nervous system demyelinating diseases in adults. Arch Neurol 2003; 60: 504\u2013509.","journal-title":"Arch Neurol"},{"key":"135_CR68","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJM200102013440502","volume":"344","author":"A Ascherio","year":"2001","unstructured":"Ascherio A, Zhang SM, Hern\u00e1n MA, Olek MJ, Coplan PM, Brodovicz K et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 2001; 344: 327\u2013332.","journal-title":"N Engl J Med"},{"key":"135_CR69","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/08916930500144484","volume":"38","author":"DA Geier","year":"2005","unstructured":"Geier DA, Geier MR. A case\u2013control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity 2005; 38: 295\u2013301.","journal-title":"Autoimmunity"},{"key":"135_CR70","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1212\/01.WNL.0000138433.61870.82","volume":"63","author":"MA Hern\u00e1n","year":"2004","unstructured":"Hern\u00e1n MA, Jick SS, Olek MJ, Jick H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study. Neurology 2004; 63: 838\u2013842.","journal-title":"Neurology"},{"key":"135_CR71","first-page":"1436","volume":"4","author":"M Girard","year":"2007","unstructured":"Girard M. When evidence-based medicine (EBM) fuels confusion: multiple sclerosis after hepatitis B vaccine as a case in point. Med Veritas 2007; 4: 1436\u20131451.","journal-title":"Med Veritas"},{"key":"135_CR72","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1056\/NEJM200106073442313","volume":"344","author":"B B\u00e9gaud","year":"2001","unstructured":"B\u00e9gaud B, Alp\u00e9rovitch A. Vaccinations and multiple sclerosis. N Engl J Med 2001; 344: 1793\u20131796.","journal-title":"N Engl J Med"},{"key":"135_CR73","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/17402520500285247","volume":"12","author":"D-P Bogdanos","year":"2005","unstructured":"Bogdanos D-P, Smith H, Ma Y, Baum H, Mieli-Vergani G, Vergani D. A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics. Clin Dev Immunol 2005; 12: 217\u2013224.","journal-title":"Clin Dev Immunol"},{"key":"135_CR74","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1016\/j.vaccine.2004.01.056","volume":"22","author":"J Poirriez","year":"2004","unstructured":"Poirriez J. A preliminary experiment of absorption of antinuclear antibodies by the hepatitis B vaccine components, in a case of neurolupus. Vaccine 2004; 22: 3166\u20133168.","journal-title":"Vaccine"},{"key":"135_CR75","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.mehy.2005.02.044","volume":"65","author":"E Faure","year":"2005","unstructured":"Faure E. Multiple sclerosis and hepatitis B vaccination: could minute contamination of the vaccine by partial hepatitis B virus polymerase play a role through molecular mimicry? Med Hypotheses 2005; 65: 509\u2013520.","journal-title":"Med Hypotheses"},{"key":"135_CR76","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.phrs.2014.08.002","volume":"92","author":"A Soriano","year":"2015","unstructured":"Soriano A, Nesher G, Shoenfeld Y. Predicting post-vaccination autoimmunity: who might be at risk? Pharmacol Res 2015; 92: 18\u201322.","journal-title":"Pharmacol Res"},{"key":"135_CR77","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcancer.2013.11.002","volume":"26","author":"M Tommasino","year":"2014","unstructured":"Tommasino M. The human papillomavirus family and its role in carcinogenesis. Semin Cancer Biol 2014; 26: 13\u201321.","journal-title":"Semin Cancer Biol"},{"key":"135_CR78","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1001\/jama.2016.17615","volume":"316","author":"O-E Iversen","year":"2016","unstructured":"Iversen O-E, Miranda MJ, Ulied A, Soerdal T, Lazarus E, Chokephaibulkit K et al. Immunogenicity of the 9-valent HPV vaccine using 2-dose regimens in girls and boys vs a 3-dose regimen in women. JAMA 2016; 316: 2411\u20132421.","journal-title":"JAMA"},{"key":"135_CR79","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","volume":"374","author":"J Paavonen","year":"2009","unstructured":"Paavonen J, Naud P, Salmer\u00f3n J, Wheeler CM, Chow S-N, Apter D et al. Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet Lond Engl 2009; 374: 301\u2013314.","journal-title":"Lancet Lond Engl"},{"key":"135_CR80","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1056\/NEJMoa061760","volume":"356","author":"SM Garland","year":"2007","unstructured":"Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007; 356: 1928\u20131943.","journal-title":"N Engl J Med"},{"key":"135_CR81","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.autrev.2014.01.054","volume":"13","author":"P Pellegrino","year":"2014","unstructured":"Pellegrino P, Carnovale C, Pozzi M, Antoniazzi S, Perrone V, Salvati D et al. On the relationship between human papilloma virus vaccine and autoimmune diseases. Autoimmun Rev 2014; 13: 736\u2013741.","journal-title":"Autoimmun Rev"},{"key":"135_CR82","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1517\/14740338.2015.1073710","volume":"14","author":"B Baker","year":"2015","unstructured":"Baker B, E\u00e7a Guimar\u00e3es L, Tomljenovic L, Agmon-Levin N, Shoenfeld Y. The safety of human papilloma virus-blockers and the risk of triggering autoimmune diseases. Expert Opin Drug Saf 2015; 14: 1387\u20131394.","journal-title":"Expert Opin Drug Saf"},{"key":"135_CR83","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1001\/jama.2009.1201","volume":"302","author":"BA Slade","year":"2009","unstructured":"Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA 2009; 302: 750\u2013757.","journal-title":"JAMA"},{"key":"135_CR84","unstructured":"Cramon C, Poulsen CL, Hartling UB, Holden IK, Johansen IS. Possible adverse effects of the quadrivalent human papillomavirus vaccine in the Region of Southern Denmark: a retrospective, descriptive cohort study. Dan Med J 2017; 64."},{"key":"135_CR85","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1001\/archpediatrics.2012.1451","volume":"166","author":"NP Klein","year":"2012","unstructured":"Klein NP, Hansen J, Chao C, Velicer C, Emery M, Slezak J et al. Safety of quadrivalent human papillomavirus vaccine administered routinely to females. Arch Pediatr Adolesc Med 2012; 166: 1140\u20131148.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"135_CR86","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/joim.12535","volume":"280","author":"O Gr\u00f6nlund","year":"2016","unstructured":"Gr\u00f6nlund O, Herweijer E, Sundstr\u00f6m K, Arnheim-Dahlstr\u00f6m L. Incidence of new-onset autoimmune disease in girls and women with pre-existing autoimmune disease after quadrivalent human papillomavirus vaccination: a cohort study. J Intern Med 2016; 280: 618\u2013626.","journal-title":"J Intern Med"},{"key":"135_CR87","first-page":"30","volume":"2","author":"T Jefferson","year":"2017","unstructured":"Jefferson T, J\u00f8rgensen L. Human papillomavirus vaccines, complex regional pain syndrome, postural orthostatic tachycardia syndrome, and autonomic dysfunction\u2014a review of the regulatory evidence from the European Medicines Agency. Indian J Med Ethics 2017; 2: 30\u201337.","journal-title":"Indian J Med Ethics"},{"key":"135_CR88","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/joim.12575","volume":"281","author":"S Dahan","year":"2017","unstructured":"Dahan S, Shoenfeld Y. Letter to the editor\u2014HPV vaccine and autoimmunity Incidence of new-onset autoimmune disease in girls and women with pre-existing autoimmune disease after quadrivalent human papillomavirus vaccination: a cohort study. J Intern Med 2017; 281: 313\u2013315.","journal-title":"J Intern Med"},{"key":"135_CR89","first-page":"383","volume":"1","author":"D Kanduc","year":"2009","unstructured":"Kanduc D. Penta- and hexapeptide sharing between HPV16 and Homo sapiens proteomes. Int J Med Med Sci 2009; 1: 383\u2013387.","journal-title":"Int J Med Med Sci"},{"key":"135_CR90","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1046\/j.1440-1711.2000.00949.x","volume":"78","author":"C Natale","year":"2000","unstructured":"Natale C, Giannini T, Lucchese A, Kanduc D. Computer-assisted analysis of molecular mimicry between human papillomavirus 16 E7 oncoprotein and human protein sequences. Immunol Cell Biol 2000; 78: 580\u2013585.","journal-title":"Immunol Cell Biol"},{"key":"135_CR91","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1177\/0961203310372952","volume":"19","author":"EM Klumb","year":"2010","unstructured":"Klumb EM, Pinto AC, Jesus GR, Araujo M, Jascone L, Gayer CR et al. Are women with lupus at higher risk of HPV infection? Lupus 2010; 19: 1485\u20131491.","journal-title":"Lupus"},{"key":"135_CR92","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00296-012-2426-0","volume":"33","author":"LDC Lyrio","year":"2013","unstructured":"Lyrio LDC, Grassi MFR, Santana IU, Olavarria VG, Gomes A, do N, CostaPinto L et al. Prevalence of cervical human papillomavirus infection in women with systemic lupus erythematosus. Rheumatol Int 2013; 33: 335\u2013340.","journal-title":"Rheumatol Int"},{"key":"135_CR93","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s12026-016-8890-y","volume":"65","author":"Y Segal","year":"2017","unstructured":"Segal Y, Dahan S, Calabr\u00f2 M, Kanduc D, Shoenfeld Y. HPV and systemic lupus erythematosus: a mosaic of potential crossreactions. Immunol Res 2017; 65: 564\u2013571.","journal-title":"Immunol Res"},{"key":"135_CR94","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/BOR.0000000000000398","volume":"29","author":"Y Segal","year":"2017","unstructured":"Segal Y, Calabr\u00f2 M, Kanduc D, Shoenfeld Y. Human papilloma virus and lupus: the virus, the vaccine and the disease. Curr Opin Rheumatol 2017; 29: 331\u2013342.","journal-title":"Curr Opin Rheumatol"},{"key":"135_CR95","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s10067-013-2266-7","volume":"32","author":"M Gatto","year":"2013","unstructured":"Gatto M, Agmon-Levin N, Soriano A, Manna R, Maoz-Segal R, Kivity S et al. Human papillomavirus vaccine and systemic lupus erythematosus. Clin Rheumatol 2013; 32: 1301\u20131307.","journal-title":"Clin Rheumatol"},{"key":"135_CR96","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1177\/0961203311429556","volume":"21","author":"HF Soldevilla","year":"2012","unstructured":"Soldevilla HF, Briones SFR, Navarra SV. Systemic lupus erythematosus following HPV immunization or infection? Lupus 2012; 21: 158\u2013161.","journal-title":"Lupus"},{"key":"135_CR97","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2177\/jsci.39.145","volume":"39","author":"H Ito","year":"2016","unstructured":"Ito H, Noda K, Hirai K, Ukichi T, Furuya K, Kurosaka D. A case of systemic lupus erythematosus (SLE) following human papillomavirus (HPV) vaccination. Nihon Rinsho Meneki Gakkai Kaishi 2016; 39: 145\u2013149.","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"135_CR98","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.autrev.2017.05.012","volume":"16","author":"B Wang","year":"2017","unstructured":"Wang B, Shao X, Wang D, Xu D, Zhang J-A. Vaccinations and risk of systemic lupus erythematosus and rheumatoid arthritis: a systematic review and meta-analysis. Autoimmun Rev 2017; 16: 756\u2013765.","journal-title":"Autoimmun Rev"},{"key":"135_CR99","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12026-016-8815-9","volume":"65","author":"DA Geier","year":"2016","unstructured":"Geier DA, Geier MR. Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case\u2013control assessment of the vaccine adverse event reporting system (VAERS) database. Immunol Res 2016; 65: 46\u201354.","journal-title":"Immunol Res"},{"key":"135_CR100","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1540-8167.2006.00575.x","volume":"17","author":"BP Grubb","year":"2006","unstructured":"Grubb BP, Kanjwal Y, Kosinski DJ. The postural tachycardia syndrome: a concise guide to diagnosis and management. J Cardiovasc Electrophysiol 2006; 17: 108\u2013112.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"135_CR101","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/mus.24245","volume":"50","author":"C-A Haensch","year":"2014","unstructured":"Haensch C-A, Tosch M, Katona I, Weis J, Isenmann S. Small-fiber neuropathy with cardiac denervation in postural tachycardia syndrome. Muscle Nerve 2014; 50: 956\u2013961.","journal-title":"Muscle Nerve"},{"key":"135_CR102","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1540-8167.2008.01407.x","volume":"20","author":"PA Low","year":"2009","unstructured":"Low PA, Sandroni P, Joyner M, Shen W-K. Postural Tachycardia Syndrome (POTS). J Cardiovasc Electrophysiol 2009; 20: 352\u2013358.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"135_CR103","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s10067-015-2969-z","volume":"34","author":"M Mart\u00ednez-Lav\u00edn","year":"2015","unstructured":"Mart\u00ednez-Lav\u00edn M. Hypothesis: human papillomavirus vaccination syndrome\u2014small fiber neuropathy and dysautonomia could be its underlying pathogenesis. Clin Rheumatol 2015; 34: 1165\u20131169.","journal-title":"Clin Rheumatol"},{"issue":"(Suppl 1)","key":"135_CR104","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1097\/j.pain.0000000000000411","volume":"157","author":"N \u00dc\u00e7eyler","year":"2016","unstructured":"\u00dc\u00e7eyler N. Small fiber pathology\u2014a culprit for many painful disorders? Pain 2016; 157 (Suppl 1): S60\u2013S66.","journal-title":"Pain"},{"key":"135_CR105","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1177\/0961203316629558","volume":"25","author":"S Dahan","year":"2016","unstructured":"Dahan S, Tomljenovic L, Shoenfeld Y. Postural orthostatic tachycardia syndrome (POTS)\u2014a novel member of the autoimmune family. Lupus 2016; 25: 339\u2013342.","journal-title":"Lupus"},{"key":"135_CR106","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/prca.201200049","volume":"6","author":"X-L Wang","year":"2012","unstructured":"Wang X-L, Chai Q, Charlesworth MC, Figueroa JJ, Low P, Shen W-K et al. Autoimmunoreactive IgGs from patients with postural orthostatic tachycardia syndrome. Proteomics Clin Appl 2012; 6: 615\u2013625.","journal-title":"Proteomics Clin Appl"},{"key":"135_CR107","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1111\/j.1468-1331.2010.03021.x","volume":"17","author":"S Blitshteyn","year":"2010","unstructured":"Blitshteyn S. Postural tachycardia syndrome after vaccination with Gardasil. Eur J Neurol 2010; 17: e52.","journal-title":"Eur J Neurol"},{"key":"135_CR108","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/ene.12272","volume":"21","author":"S Blitshteyn","year":"2014","unstructured":"Blitshteyn S. Postural tachycardia syndrome following human papillomavirus vaccination. Eur J Neurol 2014; 21: 135\u2013139.","journal-title":"Eur J Neurol"},{"key":"135_CR109","first-page":"1","volume":"2","author":"L Tomljenovic","year":"2014","unstructured":"Tomljenovic L, Colafrancesco S, Perricone C, Shoenfeld Y. Postural orthostatic tachycardia with chronic fatigue after HPV vaccination as part of the \u2018autoimmune\/auto-inflammatory syndrome induced by adjuvants\u2019: case report and literature review. J Investig Med High Impact Case Rep 2014; 2: 1\u20138.","journal-title":"J Investig Med High Impact Case Rep"},{"key":"135_CR110","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1016\/j.vaccine.2015.03.098","volume":"33","author":"LS Brinth","year":"2015","unstructured":"Brinth LS, Pors K, Theibel AC, Mehlsen J. Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus. Vaccine 2015; 33: 2602\u20132605.","journal-title":"Vaccine"},{"key":"135_CR111","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.1016\/j.vaccine.2016.05.029","volume":"34","author":"JE Hendrickson","year":"2016","unstructured":"Hendrickson JE, Tormey CA. Human papilloma virus vaccination and dysautonomia: considerations for autoantibody evaluation and HLA typing. Vaccine 2016; 34: 4468.","journal-title":"Vaccine"},{"key":"135_CR112","first-page":"A5064","volume":"62","author":"L Brinth","year":"2015","unstructured":"Brinth L, Theibel AC, Pors K, Mehlsen J. Suspected side effects to the quadrivalent human papilloma vaccine. Dan Med J 2015; 62: A5064.","journal-title":"Dan Med J"},{"key":"135_CR113","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s12026-016-8820-z","volume":"65","author":"B Palmieri","year":"2017","unstructured":"Palmieri B, Poddighe D, Vadal\u00e0 M, Laurino C, Carnovale C, Clementi E. Severe somatoform and dysautonomic syndromes after HPV vaccination: case series and review of literature. Immunol Res 2017; 65: 106\u2013116.","journal-title":"Immunol Res"},{"key":"135_CR114","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/CND.0000000000000130","volume":"18","author":"J Kafaie","year":"2016","unstructured":"Kafaie J, Kim M, Krause E. Small fiber neuropathy following vaccination. J Clin Neuromuscul Dis 2016; 18: 37\u201340.","journal-title":"J Clin Neuromuscul Dis"},{"key":"135_CR115","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s40264-016-0456-3","volume":"40","author":"RE Chandler","year":"2017","unstructured":"Chandler RE, Juhlin K, Fransson J, Caster O, Edwards IR, Nor\u00e9n GN. Current safety concerns with human papillomavirus vaccine: a cluster analysis of reports in VigiBase\u00ae. Drug Saf 2017; 40: 81\u201390.","journal-title":"Drug Saf"},{"key":"135_CR116","doi-asserted-by":"crossref","first-page":"e000755","DOI":"10.1161\/JAHA.113.000755","volume":"3","author":"H Li","year":"2014","unstructured":"Li H, Yu X, Liles C, Khan M, Vanderlinde-Wood M, Galloway A et al. Autoimmune basis for postural tachycardia syndrome. J Am Heart Assoc 2014; 3: e000755.","journal-title":"J Am Heart Assoc"},{"key":"135_CR117","doi-asserted-by":"publisher","first-page":"8234","DOI":"10.4049\/jimmunol.177.11.8234","volume":"177","author":"Y Li","year":"2006","unstructured":"Li Y, Heuser JS, Cunningham LC, Kosanke SD, Cunningham MW. Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J Immunol 2006; 177: 8234\u20138240.","journal-title":"J Immunol"},{"key":"135_CR118","first-page":"159","volume":"9","author":"D Kanduc","year":"2011","unstructured":"Kanduc D. Potential cross-reactivity between HPV16 L1 protein and sudden death-associated antigens. J Exp Ther Oncol 2011; 9: 159\u2013165.","journal-title":"J Exp Ther Oncol"},{"key":"135_CR119","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12916-015-0306-7","volume":"13","author":"M Versini","year":"2015","unstructured":"Versini M, Jeandel P-Y, Bashi T, Bizzaro G, Blank M, Shoenfeld Y. Unraveling the hygiene hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications. BMC Med 2015; 13: 81.","journal-title":"BMC Med"},{"key":"135_CR120","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/0092-8674(95)90348-8","volume":"80","author":"KW Wucherpfennig","year":"1995","unstructured":"Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80: 695\u2013705.","journal-title":"Cell"},{"key":"135_CR121","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.autrev.2016.07.030","volume":"15","author":"D Kanduc","year":"2016","unstructured":"Kanduc D, Shoenfeld Y. From HBV to HPV: designing vaccines for extensive and intensive vaccination campaigns worldwide. Autoimmun Rev 2016; 15: 1054\u20131061.","journal-title":"Autoimmun Rev"}],"container-title":["Cellular & Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cmi2017151.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cmi2017151","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/cmi.2017.151","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/cmi2017151.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T09:19:19Z","timestamp":1684401559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cmi2017151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,5]]},"references-count":121,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["135"],"URL":"https:\/\/doi.org\/10.1038\/cmi.2017.151","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,5]]},"assertion":[{"value":"25 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Prof. Yehuda Shoenfeld has served as an expert witness in cases involving adverse vaccine reaction in the no-fault US National Vaccine Injury Compensation Program.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}